Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

11110	Companies
244477	Keywords
172514	Articles
131726	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/16/2025 at 12:00, 1 year ago

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant

FDA Approval COVID-19 Vaccine Moderna Spikevax Neutralizing Antibodies
BRIEF

published on 09/02/2025 at 13:05, 1 year ago

Moderna présentera ses données thérapeutiques à base d'ARNm à l'ICIEM 2025

Moderne Acidémie Propionique ICIEM Thérapeutique Par ARNm Acidémie Méthylmalonique
BRIEF

published on 09/02/2025 at 13:05, 1 year ago

Moderna to Present mRNA Therapeutics Data at 2025 ICIEM

MRNA Therapeutics Moderna Propionic Acidemia ICIEM Methylmalonic Acidemia
PRESS RELEASE

published on 09/02/2025 at 13:00, 1 year ago

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a

Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF

published on 08/27/2025 at 19:29, 1 year 1 month ago

Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA

FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
BRIEF

published on 08/27/2025 at 19:29, 1 year 1 month ago

Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine

Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
PRESS RELEASE

published on 08/27/2025 at 19:24, 1 year 1 month ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon

FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF

published on 08/22/2025 at 15:30, 1 year 1 month ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine

COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF

published on 08/22/2025 at 15:30, 1 year 1 month ago

Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour

Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE

published on 08/22/2025 at 15:25, 1 year 1 month ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted

COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing

Accesswire

Published on 10/01/2026 at 13:45, 16 minutes ago

Quartz Mountain Upsizes Financing to $1.71 Million
Published on 10/01/2026 at 13:30, 31 minutes ago

Electric Metals (USA) Limited Announces Grant of Deferred Share Units
Published on 10/01/2026 at 13:30, 31 minutes ago

AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services
Published on 10/01/2026 at 13:30, 31 minutes ago

LNG Energy Group Corp. Announces Extension of Non-Brokered Offering
Published on 10/01/2026 at 08:02, 5 hours 59 minutes ago

Southern Energy Announces Results of Annual Meeting and Board Changes

View all ACCESSWIRE

EQS Group

Published on 10/01/2026 at 13:56, 5 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 10/01/2026 at 13:53, 8 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 10/01/2026 at 13:52, 8 minutes ago

EQS-Adhoc: innoscripta SE: Searches at innoscripta Group entities in connection with investigations relating to research allowances
Published on 10/01/2026 at 13:35, 26 minutes ago

Medline launches "10 Minutes That Matter" campaign to spotlight the value of time in the operating theatre
Published on 10/01/2026 at 13:35, 26 minutes ago

DeFi Technologies Provides September Corporate Update: Valour Reports $640.2 Million in AUM, Up 61.2% from Q2 End

Les Echos

Published on 10/01/2026 at 10:46, 3 hours 15 minutes ago

Déclaration des transactions sur actions propres réalisées du 21/09/2026 au 25/09/2026
Published on 10/01/2026 at 10:46, 3 hours 15 minutes ago

Statement of transactions in own shares from September 21, 2026 to September 25, 2026
Published on 10/01/2026 at 09:54, 4 hours 7 minutes ago

Septembre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/01/2026 at 08:30, 5 hours 31 minutes ago

Eurazeo opens an office in Abu Dhabi, reinforcing its commitment to the Middle East
Published on 10/01/2026 at 08:30, 5 hours 31 minutes ago

Cegedim Business Services dévoile Hospi-DM, sa nouvelle offre SaaS de traçabilité des dispositifs médicaux, lors des 36èmes Journées Euro-Pharmat

View all LES ECHOS COMFI WIRE